Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Syros Pharmaceuticals Inc
SYRSCurrent price
0.36 USD
-0.039 USD (-9.69%)
Last closed
2.73 USD
Company
www.syros.com
ISIN
US87184Q1076
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
70 032 824 USD
Yield for 12 month
-86.80 %
1Y
3Y
5Y
10Y
15Y
SYRS
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts. Address: 35 CambridgePark Drive, Cambridge, MA, United States, 02140
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
8.75 USDP/E ratio
–Dividend Yield
–Current Year
+9 936 000 USD
Last Year
+14 880 000 USD
Current Quarter
–
Last Quarter
–
Current Year
+7 684 000 USD
Last Year
+11 913 000 USD
Current Quarter
-325 000 USD
Last Quarter
-331 000 USD
Key Figures SYRS
1 year
3 years
5 years
10 years
EBITDA
-110 180 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-59.88 %
PEG Ratio
–
Return On Equity TTM
-776.96 %
Wall Street Target Price
8.75 USD
Revenue TTM
386 000 USD
Book Value
-0.42 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-3.3 %
Dividend Yield
–
Gross Profit TTM
14 880 000 USD
Earnings per share
-3.07 USD
Diluted Eps TTM
-3.07 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics SYRS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SYRS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
19.09.2022
Dividend Date
–
Stock Valuation SYRS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
186.4863
Price Sales TTM
181.4322
Enterprise Value EBITDA
-0.4144
Price Book MRQ
10.6509
Financials SYRS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SYRS
For 52 weeks
1.43 USD
8.17 USD
50 Day MA
2.01 USD
Shares Short Prior Month
999 929
200 Day MA
4.63 USD
Short Ratio
4.74
Shares Short
952 604
Short Percent
3.86 %
BeatStart